Study of resistance to antituberculous drugs in Spain
Casal, M.
Revista Latinoamericana de Microbiologia 22(4): 161-162
1980
ISSN/ISBN: 0187-4640 PMID: 6794121 Document Number: 162367
Document emailed within 1 workday
Related Documents
Baba, H. 1994: Studies on the problems of resistance to antituberculous drugs. II--1. Clinically applicable criteria of drug-resistance to rifampicin Kekkaku: 69(6): 387-396Delás, M.A.; Martínez, C.; Yagüe, C.; Rodríguez, T.; Rodríguez, T.; Segovia, M. 2001: Comparative study of 3 tests for susceptibility of Mycobacterium tuberculosis to first-line antituberculous drugs Revista Espanola de Quimioterapia: Publicacion Oficial de la Sociedad Espanola de Quimioterapia 14(1): 40-46
Yanaginuma, T. 1987: Administration of antituberculous drugs to subjects with basic diseases. 5. Drugs for tuberculosis in the pregnant woman Kekkaku: 62(12): 680-684
Martínez-Suárez, M.M.; Blázquez-Menes, B. 2000: Estimation of the prevalence of Parkinson's disease in Asturia, Spain. a pharmacoepidemiological study of the consumption of antiparkinson drugs Revista de Neurologia 31(11): 1001-1006
de la Hoz, R.E.; Waycott, S.; Garcia, D.; Melendez, R.; Bia, F.J. 1997: Initial screening for antituberculous drug resistance at an inpatient facility in Leon, Nicaragua American Journal of Tropical Medicine and Hygiene 56(1): 24-26
Suzuki, T. 1971: Experimental studies on intermittent use of rifampicin alone or combined with other secondary antituberculous drugs Kekkaku: 46(5): 153-164
Beggs, W.H. 1975: Growth inhibition of tubercle bacilli after pulsed exposures to combinations of antituberculous drugs Research Communications in Chemical Pathology and Pharmacology 11(3): 487-490
Szymańska, D. 1972: Histopathomorphosis of tuberculous lesions in the lungs in the course of chronic tuberculosis treated with antituberculous drugs Patologia Polska 23(3): 351-362
Bruguera, M.; Buti, M.; Diago, M.; García Bengoechea, M.; Jara, P.; Pedreira, J.A.; Ruiz Extremera, A. 1997: Indications and prescription of hepatitis A vaccine in Spain. Report of the Spain Association for the Study of the Liver Gastroenterologia y Hepatologia 20(9): 467-473
Minakuchi, M.; Tanaka, E.; Inoue, T.; Sakuramoto, M.; Maeda, Y.; Maniwa, K.; Taguchi, Y. 2005: An adult case of cervico-mediastinal lymph nodes tuberculosis followed by the development of pulmonary lesions during the treatment with antituberculous drugs Kekkaku: 80(1): 19-23
Woo, J.; Chan, C.; Chan, R.; Cheung, W.; Or, K.; Chan, K. 1995: Correlation between steady-state plasma concentration of antituberculous drugs and age, inclusion of rifampicin in the treatment regimen, adverse drug reactions and other clinical parameters Journal of Medicine 26(5-6): 279-294
Sayğan, M.B.; Ocak, F.; Cesur, S.; Tarhan, G.ül.; Ceyhan, I.; Gümüişlü, F.; Beker, G.ül.şa.; Güner, U.ğu.; Coşkun, E. 2007: Susceptibilities of Mycobacterium tuberculosis strains collected from regional tuberculosis laboratories to major antituberculous drugs Mikrobiyoloji Bulteni 41(3): 403-409
Valdivia Alvarez, J.A.; Jimenez Misas, C.A.; Rodriguez, R.; Mederos Cuervo, L.; Echemendia Font, M.; Valdes, L.; Suarez, R.; Gonzalez, R.; Romero, V.; Heredia, C.; Tudela, H.; Hernandez, M.; Ruiz Landa, A.; Alvarez, J. 1982: Cooperative study of resistance to antibacilli drugs in M. Tuberculosis strains isolated from Tuberculosis patients. (Preliminary study) Revista Cubana de Medicina Tropical 34(2): 119-125
Kondo, E.; Kanai, K. 1977: Experimental studies on the effective regimens of antituberculous drugs in the treatment of tuberculosis. II. Long-term chemotherapy in mice by daily and intermittent administration with changing drug combination Kekkaku: 52(8): 373-376
García de Lomas, J. 1998: The current epidemiologic situation and resistance of respiratory pathogens in Spain Medicina Clinica 110(Suppl 1): 44-51
Toyoara, M. 1972: An experimental study on the antituberculous activity of tuberactiomycin-N Kekkaku: 47(6): 181-187
Al-Shamahy, H.; Al-Harazy, A.H.; Harmal, N.S.; Al-Kabsi, A.M. 2007: The prevalence and degree of resistance of Plasmodium falciparum to first-line antimalarial drugs: an in vitro study from a malaria endemic region in Yemen Annals of Saudi Medicine 27(6): 432-436
Breier, A.; Drobná, Z.; Docolomansky, P.; Barancik, M. 2000: Cytotoxic activity of several unrelated drugs on L1210 mouse leukemic cell sublines with P-glycoprotein (PGP) mediated multidrug resistance (MDR) phenotype. A QSAR study Neoplasma 47(2): 100-106
Takashina, J. 1956: Studies on action mechanisms of antituberculous drugs. I. Studies on inhibitory action of SM, PAS, INH against BCG dehydrogenase Science Reports of the Research Institutes, Tohoku University, Series C: Medicine 7(2): 187-194
Lacal, J-Carlos.; Carnero, A. 2003: Targeted search for anticancer drugs--CNIO cancer conference. 16-18 March, Madrid, Spain IDrugs: the investigational drugs journal 6(5): 437-441